Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee

Knee Surgery, Sports Traumatology, Arthroscopy

Volumn 20, Issue 6, 2012, Pages 1159-1167

  Fotopoulos, Vasileios Christos ^a,b   Tzinia, Athina ^c   Tzurbakis, Matthew ^b   Kalfakakou, Vasiliki ^a   Levidiotou Stefanou, Stamatina ^a   Georgoulis, Anastasios ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Arthritis; Gelatinases; Knee; MMP 9; Septic; TIMP 1

Indexed keywords

BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; TIMP1 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADOLESCENT; ADULT; AGED; ARTICLE; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; HUMAN; INFECTIOUS ARTHRITIS; KNEE; KNEE OSTEOARTHRITIS; MALE; METABOLISM; MIDDLE AGED; POLYACRYLAMIDE GEL ELECTROPHORESIS; RHEUMATOID ARTHRITIS; STATISTICAL MODEL; SYNOVIAL FLUID; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, INFECTIOUS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; KNEE; LINEAR MODELS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 84861350717     PISSN: 09422056     EISSN: 14337347     Source Type: Journal    
DOI: 10.1007/s00167-011-1676-9     Document Type: Article

References (35)

1. Aasen AO, Wang JE (2006) Mediator responses in surgical infections. Surg Infect 7(suppl 2): S3-S4.
2. Arican M, Coughlan AR, Clegg PD, Carter SD (2000) MMP-2 and -9 activity in bovine synovial fluids. J Vet Med. A Physiol Pathol Clin Med 47: 449-456.
3. Calander AM, Starckx S, Opdenakker G et al (2006) Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis. Microbes Infect 8: 1434-1439.
4. Chu S, Yang S, Lue K et al (2004) Clinical significance of gelatinases in septic arthritis of native and replaced knees. Clin Orthop Rel Res 427: 179-183.
5. Elkington PTG, O'Kane CM, Friedland JS (2005) The paradox of MMPs in infectious disease. Clin Exp Immunol 142: 12-20.
6. Fernando de Souza L, Jardim FR, Sauter IP et al (2008) High glucose increases RAW 264. 7 macrophages activation by lipoteichoic acid from S. aureus. Clin Chim Acta 398: 130-133.
7. Fietz S, Einspanier R, Hoppner S et al (2008) Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays. Equine Vet J 40: 266-271.
8. Firestein GS, Budd RC, Harris ED Jr et al (2008) Kelley's textbook of rheumatology, 8th ed. Saunders, Philadelphia, pp 1-1902.
9. Francoz D, Desrochers A, Simard N et al (2008) Relative expression of matrix metalloproteinase-2 and -9 in synovial fluid from healthy calves and calves with experimentally induced septic arthritis. Am J Vet Res 69: 1022-1028.
10. Gehre F, Leib SL, Grandgirard D et al (2008) Essential role of choline for pneumococcal virulence in an experimental model of meningitis. J Intern Med 264: 143-154.
11. Goldberg GI, Strongin A, Collier IE et al (1992) Interaction of 92-kDa type IV collagenase with TIMPs prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267: 4583-4591.
12. Gupta MN, Sturrock RD, Field M (2001) A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatol (Oxford) 40: 24-30.
13. Jalian HR, Liu PT, Kanchanapoomi M et al (2008) All-trans retinoic acid shifts Propionibacterium acnes-induced matrix degradation expression profile toward matrix preservation in human monocytes. J Invest Dermatol 128: 2777-2782.
14. Jobin MC, Gottschalk M, Grenier D (2006) Upregulation of PGE2 and MMP-9 production by human macrophage-like cells: synergistic effect of capsular material and cell wall from Streptococcus suis. Microb Pathog 40: 29-34.
15. Jotwani R, Eswaran SV, Moonga S, Cutler CW (2010) MMP-9/TIMP-1 imbalance induced in human dendritic cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol 58: 314-321.
16. Kanangat S, Postlethwaite A, Hasty K et al (2006) Induction of multiple MMPs in human dermal and synovial fibroblasts by S. aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthr Res Ther 8: R176.
17. Kleiner DE, Stetler-Stevenson WG (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325-329.
18. Lorente L, Martin MM, Labarta L et al (2009) Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 13: 1006.
19. Ma L, Cranney A, Holroyd-Leduc JM (2009) Acute monoarthritis: what is the cause of my patient's painful swollen joint? CMAJ 180: 59-65.
20. Makowski GS, Ramsby ML (2003) Zymographic analysis of latent and activated forms of MMP-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection. Clin Chim Acta 329: 77-81.
21. Margaretten ME, Kohlwes J, Moore D, Bent S (2007) Does this patient have septic arthritis? JAMA 297: 1478-1488.
22. Oggioni MR, Memmi G, Maggi T et al (2003) Pneumococcal zinc metalloproteinase ZmpC cleaves human MMP-9 and is a virulence factor in experimental pneumonia. Mol Microbiol 49: 795-805.
23. Okada Y, Naka K, Kawamura K et al (1995) Localization of MMP-9 in osteoclasts: implications for bone resorption. Lab Invest 72: 311-322.
24. Punzi L, Oliviero F, Plebani M (2005) New biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment. Crit Rev Clin Lab Sci 42: 279-309.
25. Schaaf B, Liebau C, Kurowski V et al (2008) Hospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activity. BMC Pulm Med 8: 12.
26. Sellner J, Leib SL (2006) In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation. Neurobiol Dis 21: 647-656.
27. Snoek-van Beurden PA, von den Hoff JW (2005) Zymographic techniques for the analysis of MMPs and their inhibitors. Biotechniques 38: 73-83.
28. Taggart CC, Greene CM, Carroll TP et al (2005) Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease. Am J Respir Crit Care Med 171: 1070-1076.
29. Tamura F, Nakagawa R, Akuta T et al (2004) Proapoptotic effect of proteolytic activation of MMPs by Streptococcus pyogenes thiol proteinase. Infect Immun 72: 4836-4847.
30. Tanabe S, Bodet C, Grenier D (2007) Peptostreptococcus micros cell wall elicits a pro-inflammatory response in human macrophages. J Endotoxin Res 13: 219-226.
31. Triebel S, Blaser J, Reinke H, Tschesche H (1992) A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett 314: 386-388.
32. van Doren SR, Wei S, Gao G et al (2008) Inactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria. Biopolymers 89: 960-968.
33. Visser S, Tupper J (2009) Septic until proven otherwise. Approach to and treatment of the septic joint in adult patients. Can Fam Phys 55: 374-375.
34. Wang JE, Pettersen S, Stuestol JF et al (2004) Peptidoglycan of S. aureus causes increased levels of MMPs in the rat. Shock 22: 376-379.
35. Wang YY, Myhre AE, Pettersen SJ et al (2005) Peptidoglycan of S. aureus induces enhanced levels of MMP-9 in human blood originating from neutrophils. Shock 24: 214-218.